AstraZeneca is trading 3.01% higher at $168.88 on October 20, 2026, amid a healthcare rally and its Oracle collaboration announcement.
- The non-binding collaboration will explore AI and real-world data applications for clinical trials, patient recruitment, diagnosis and safety monitoring; no financial terms were disclosed.
- XLV is up 2.12%; available evidence does not establish how much either development contributed to AstraZeneca’s share move.